HIV type 1-specific IgE in serum of long-term surviving children inhibits HIV type 1 production in vitro

AIDS Research and Human Retroviruses

Volumn 18, Issue 5, 2002, Pages 363-372

  Pellegrino, Michael G ^a   Bluth, Martin H ^a   Smith Norowitz, Tamar ^a   Fikrig, Senih ^a   Volsky, David J ^b   Moallem, Hamid ^a   Auci, Dominick L ^a   Nowakowski, Maja ^a   Durkin, Helen G ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; ANTIVIRUS AGENT; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 2; PHYTOHEMAGGLUTININ; PROTEIN G; SEPHAROSE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBODY AFFINITY; ARTICLE; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; CYTOTOXICITY; DONOR; FEMALE; HEAT TREATMENT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; REGULATORY MECHANISM; SCHOOL CHILD; SURVIVAL; T LYMPHOCYTE; TIME; VIROGENESIS; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS TRANSMISSION;

CD4 LYMPHOCYTE COUNT; CELLS, CULTURED; CHILD; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV ANTIBODIES; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-1; HUMANS; IMMUNOGLOBULIN E; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; T-LYMPHOCYTES; VIRUS REPLICATION;

EID: 0036207936     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922202753519142     Document Type: Article

References (31)

1. Long term survivors of HIV-1 infection: Definitions and research challenges
2. CD4 lymphopenia without clinical disease
3. Role of cellular immunity in protection against HIV infection
4. The characterization of non-progressors
5. HTLV-III neutralizing antibodies in patients with AIDS and AIDS related complex
6. Neutralization of human T lymphotropic virus type III by sera of AIDS and AIDS risk patients
7. Antibody to lymphadenopathy associated virus in AIDS
8. Relationship between HTLV-III neutralizing antibody and clinical status of pediatric AIDS and AIDS related complex cases
9. Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein
10. Prospect for prevention of human immunodeficiency virus infection: Purified 120-kDa envelope glycoprotein induces neutralizing antibody
11. Role of cellular immunity in protection against HIV infection
12. Studies of IgE bearing lymphocytes in humans
13. Elevation of IgE in HIV infected children and its correlation with progression of disease
14. The immunopathogenesis of HIV infection
15. Serum IgE and human immunodeficiency (HIV) infection
16. Elevation of IgE in HIV-infected subjects: A marker for poor prognosis
17. IgE against HIV proteins in infected children
18. IgE against HIV proteins in clinically healthy children with HIV disease
19. Cytokine profile of a long term pediatric HIV survivor with hyper IgE syndrome and a normal CD4+ T cell count
20. Strong serum inhibition of specific IgE correlated to competing IgG4 revealed by a new methodology in subjects from a S. mansoni endemic area
21. Differences in cytopathogenicity and host cell range among infectious molecular clones of HIV-1 simultaneously isolated from an individual
22. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection
23. Age related changes of lymphocyte phenotypes in healthy children
24. Lymphocyte subsets in healthy children during the first 5 years of life
25. Evaluation of immunoglobulin E specific antibodies and viral antigens in nasopharyngeal secretions of children with respiratory syncytial virus infections
26. Increased expression of CD23 (Fcε receptor II) by peripheral blood monocytes of AIDS patients
27. Role of antibody dependent cytotoxicity in defense against herpes simplex virus infection
28. Neutralizing antibodies in slowly progressing HIV-1 infection
29. Effective ex vivo neutralization of human immunodeficiency virus type I in plasma by recombinant immunoglobulin molecules